Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,948 | 127 | 99.6% |
| Education | $17.84 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Glaukos Corporation | $1,389 | 20 | $0 (2024) |
| Shire North American Group Inc | $370.23 | 28 | $0 (2019) |
| Alcon Vision LLC | $357.74 | 15 | $0 (2023) |
| Allergan Inc. | $264.11 | 5 | $0 (2019) |
| Aerie Pharmaceuticals, Inc. | $238.91 | 13 | $0 (2021) |
| Kala Pharmaceuticals, Inc. | $225.71 | 9 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $189.59 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $186.59 | 9 | $0 (2019) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $135.51 | 3 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $128.97 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $245.22 | 5 | Glaukos Corporation ($204.86) |
| 2023 | $442.18 | 11 | Glaukos Corporation ($252.03) |
| 2022 | $725.72 | 23 | GLAUKOS CORPORATION ($277.77) |
| 2021 | $623.01 | 19 | Glaukos Corporation ($282.00) |
| 2020 | $535.68 | 16 | Glaukos Corporation ($260.03) |
| 2019 | $266.39 | 5 | Allergan Inc. ($100.00) |
| 2018 | $477.63 | 25 | Shire North American Group Inc ($127.43) |
| 2017 | $649.77 | 24 | Shire North American Group Inc ($221.08) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $30.68 | General |
| Category: Glaucoma | ||||||
| 10/11/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $140.90 | General |
| Category: Glaucoma | ||||||
| 10/10/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $33.28 | General |
| Category: Glaucoma | ||||||
| 10/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Dry eyes | ||||||
| 07/30/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: EYE CARE | ||||||
| 12/18/2023 | Glaukos Corporation | iStent infinite Trabecular Micro-Bypass System Model iS3 (Device) | Food and Beverage | Cash or cash equivalent | $73.36 | General |
| Category: Glaucoma | ||||||
| 10/20/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $148.87 | General |
| 10/17/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: DRY EYE | ||||||
| 09/14/2023 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/07/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: DRY EYE | ||||||
| 08/31/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Education | In-kind items and services | $17.84 | General |
| Category: Ophthalmology | ||||||
| 08/03/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: DRY EYE | ||||||
| 05/12/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $29.80 | General |
| 04/20/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), LOTEMAX SM | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Ophthalmology | ||||||
| 04/14/2023 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Simplicity (Device) | Food and Beverage | In-kind items and services | $68.79 | General |
| Category: Optics | ||||||
| 01/18/2023 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Ophthalmology | ||||||
| 12/14/2022 | Alcon Vision LLC | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Glaucoma | ||||||
| 12/14/2022 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), ZYLET, ALREX | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Ophthalmology | ||||||
| 12/14/2022 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), ALREX, ZYLET | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: Ophthalmology | ||||||
| 11/08/2022 | Alcon Vision LLC | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Glaucoma | ||||||
| 11/02/2022 | GLAUKOS CORPORATION | ISTENT INJECT W (Device), IACCESS | Food and Beverage | Cash or cash equivalent | $67.14 | General |
| Category: GLAUCOMA | ||||||
| 10/26/2022 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Ophthalmology | ||||||
| 10/11/2022 | Alcon Vision LLC | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Glaucoma | ||||||
| 09/14/2022 | Alcon Vision LLC | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $3.50 | General |
| Category: Glaucoma | ||||||
| 08/16/2022 | Alcon Vision LLC | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Glaucoma | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,878 | 2,056 | $483,336 | $134,670 |
| 2022 | 12 | 1,690 | 1,832 | $238,177 | $124,726 |
| 2021 | 10 | 1,524 | 1,726 | $220,683 | $120,778 |
| 2020 | 11 | 1,073 | 1,163 | $151,281 | $85,443 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 893 | 971 | $272,440 | $76,537 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 255 | 339 | $80,700 | $21,628 | 26.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 114 | 114 | $37,829 | $10,465 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $24,840 | $7,244 | 29.2% |
| 92134 | Imaging of retina | Office | 2023 | 210 | 212 | $22,260 | $5,746 | 25.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 79 | 82 | $13,038 | $3,585 | 27.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 132 | 135 | $12,825 | $3,387 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 28 | $7,500 | $2,647 | 35.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 19 | 19 | $4,049 | $1,283 | 31.7% |
| 92250 | Photography of the retina | Office | 2023 | 52 | 53 | $3,975 | $1,203 | 30.3% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 14 | 14 | $2,240 | $697.90 | 31.2% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 13 | 20 | $1,640 | $247.45 | 15.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 849 | 926 | $129,640 | $74,045 | 57.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 182 | 241 | $21,690 | $15,305 | 70.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 113 | 113 | $18,645 | $9,850 | 52.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 93 | 93 | $16,740 | $9,282 | 55.5% |
| 92134 | Imaging of retina | Office | 2022 | 199 | 200 | $21,000 | $5,576 | 26.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 84 | 84 | $7,980 | $2,212 | 27.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 37 | 37 | $3,885 | $2,204 | 56.7% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 11 | 14 | $5,208 | $1,943 | 37.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 41 | 41 | $6,519 | $1,711 | 26.2% |
| 92250 | Photography of the retina | Office | 2022 | 48 | 50 | $3,750 | $1,396 | 37.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $1,560 | $865.80 | 55.5% |
| 92132 | Imaging of front third of eye | Office | 2022 | 20 | 20 | $1,560 | $335.92 | 21.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 662 | 772 | $107,870 | $63,902 | 59.2% |
About Dr. Patrick Colerick, O.D
Dr. Patrick Colerick, O.D is a Optometrist healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912057373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Colerick, O.D has received a total of $3,966 in payments from pharmaceutical and medical device companies, with $245.22 received in 2024. These payments were reported across 128 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,948).
As a Medicare-enrolled provider, Colerick has provided services to 6,165 Medicare beneficiaries, totaling 6,777 services with total Medicare billing of $465,617. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Dallas, TX
- Active Since 01/10/2007
- Last Updated 04/28/2016
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912057373
Products in Payments
- XIIDRA (Drug) $370.23
- iStent inject W (Device) $282.00
- iStent inject Trabecular Micro-Bypass Stent System (Device) $260.03
- rocklatan (Drug) $254.84
- RESTASIS (Drug) $247.64
- iDose (Device) $204.86
- ISTENT INJECT W (Device) $180.12
- VYZULTA (Drug) $171.75
- rhopressa (Drug) $167.94
- EYSUVIS (Drug) $125.00
- ZYLET (Drug) $122.60
- iSTENT iNJECT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $112.48
- INVELTYS (Drug) $100.71
- IACCESS (Device) $97.65
- CEQUA (Drug) $96.14
- ORA (Device) $87.73
- TYRVAYA (Drug) $78.24
- Photrexa (Drug) $74.81
- iStent infinite Trabecular Micro-Bypass System Model iS3 (Device) $73.36
- Tecnis Simplicity (Device) $68.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Dallas
Dr. Laurence Thomas, O.d, O.D
Optometrist — Payments: $163,565
Kenneth Uzick, O.d, O.D
Optometrist — Payments: $61,059
Amanda Hoelscher, Od, OD
Optometrist — Payments: $16,203
Dr. Linda Hatton, O.d, O.D
Optometrist — Payments: $14,670
Dr. Slayton Ebeling, O.d, O.D
Optometrist — Payments: $13,635
Michael Burton, Od, OD
Optometrist — Payments: $12,447